BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17526372)

  • 1. Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization.
    Li D; Opas EE; Tuluc F; Metzger DL; Hou C; Hakonarson H; Levine MA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1774-83. PubMed ID: 24823460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association.
    Sheldon RS; Becker WJ; Hanley DA; Culver RL
    Can J Neurol Sci; 1987 Nov; 14(4):622-5. PubMed ID: 3690435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross sectional study of growth of children with sickle cell disease, aged 2 to 5 years in Yaoundé, Cameroon.
    Ngo Um SS; Seungue J; Alima AY; Mbono R; Mbassi H; Chelo D; Koki PO
    Pan Afr Med J; 2019; 34():85. PubMed ID: 31934228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V; Eleftheriou A; Malaventura C;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine complications in thalassaemia major.
    De Sanctis V; Vullo C; Katz M; Wonke B; Hoffbrand VA; Di Palma A; Bagni B
    Prog Clin Biol Res; 1989; 309():77-83. PubMed ID: 2780752
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR; De Sanctis V; Gilli G
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe chronic anemia and endocrine disorders in children].
    Hauschild M; Theintz G
    Rev Med Suisse; 2007 Apr; 3(107):988-91. PubMed ID: 17526372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine complications in patients with Thalassaemia Major.
    Toumba M; Sergis A; Kanaris C; Skordis N
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the recognition and treatment of endocrine complications in children with chronic illness.
    Zeitler PS; Travers S; Kappy MS
    Adv Pediatr; 1999; 46():101-49. PubMed ID: 10645463
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.